摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-甲基-4-氧代喹唑啉-2-羧酸乙酯 | 88267-66-7

中文名称
1-甲基-4-氧代喹唑啉-2-羧酸乙酯
中文别名
——
英文名称
2-ethoxycarbonyl-1-methyl-4(1H)-quinazolinone
英文别名
Ethyl 1-methyl-4-oxo-1,4-dihydroquinazoline-2-carboxylate;ethyl 1-methyl-4-oxoquinazoline-2-carboxylate
1-甲基-4-氧代喹唑啉-2-羧酸乙酯化学式
CAS
88267-66-7
化学式
C12H12N2O3
mdl
——
分子量
232.239
InChiKey
CBDKDWUIWXUANJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.5
  • 重原子数:
    17
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    59
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • SUBSTITUTED 2- AMIDOQUINAZOL-4-ONES AS MATRIX METALLOPROTEINASE-13 INHIBITORS
    申请人:Takeda Pharmaceutical Company Limited
    公开号:US20150329556A1
    公开(公告)日:2015-11-19
    The present invention provides a novel amide derivative having a matrix metalloproteinase inhibitory activity, and useful as a pharmaceutical agent, which is a compound represented by the formula (I) wherein ring A is an optionally substituted, nitrogen containing heterocycle, ring B is an optionally substituted monocyclic homocycle or an optionally substituted monocyclic heterocycle, Z is N or NR 1 (R 1 is a hydrogen atom or an optionally substituted hydrocarbon group), is a single bond or a double bond, R 2 is a hydrogen atom or an optionally substituted hydrocarbon group, X is an optionally substituted spacer having 1 to 6 atoms, ring C is (1) an optionally substituted homocycle or (2) an optionally substituted heterocycle other than a ring represented by (II) (X′ is S, O, SO, or CH 2 ), and at least one of ring B and ring C has substituent(s), provided that N-(1S,2R)-1-(3,5-difluorobenzyl)-3-[(3-ethylbenzyl)amino]2 hydroxypropyl}5,6 dimethyl 4 oxo 1,4 dihydrothieno[2,3-d]pyrimidine-2-carboxamide is excluded, or a salt thereof.
    本发明提供了一种新型酰胺衍生物,具有基质金属蛋白酶抑制活性,并且作为药用剂是有用的,该化合物由以下式(I)表示,其中环A是一个可选择取代的含氮杂环,环B是一个可选择取代的单环同核环或可选择取代的单环杂环,Z是N或NR1(R1是氢原子或可选择取代的碳氢基团),是一个单键或双键,R2是氢原子或可选择取代的碳氢基团,X是一个具有1到6个原子的可选择取代的间隔物,环C是(1)一个可选择取代的同核环或(2)一个除了由(II)表示的环之外的可选择取代的杂环(X′是S、O、SO或CH2),并且环B和环C中至少有一个有取代基,但不包括N-(1S,2R)-1-(3,5-二氟苄基)-3-[(3-乙基苄基)氨基]2-羟基丙基}5,6-二甲基-4-氧代-1,4-二氢噻唑并[2,3-d]嘧啶-2-羧酰胺,或其盐。
  • OZAKI, KEN-ICHI;YAMADA, YOSHIHISA;OINE, TOYONARI, CHEM. AND PHARM. BULL., 1983, 31, N 7, 2234-2243
    作者:OZAKI, KEN-ICHI、YAMADA, YOSHIHISA、OINE, TOYONARI
    DOI:——
    日期:——
  • HETEROCYCLIC AMIDE COMPOUND AND USE THEREOF AS AN MMP-13 INHIBITOR
    申请人:Takeda Pharmaceutical Company Limited
    公开号:EP1740551B1
    公开(公告)日:2012-09-12
  • Heterocyclic Amide Compound and Use Thereof as an Mmp-13 Inhibitor(Amended Ex Officio)
    申请人:Terauchi Jun
    公开号:US20080027050A1
    公开(公告)日:2008-01-31
    The present invention provides a novel amide derivative having a matrix metalloproteinase inhibitory activity, and useful as a pharmaceutical agent, which is a compound represented by the formula (I) wherein ring A is an optionally substituted, nitrogen-containing heterocycle, ring B is an optionally substituted monocyclic homocycle or an optionally substituted monocyclic heterocycle, Z is N or NR 1 (R 1 is a hydrogen atom or an optionally substituted hydrocarbon group), is a single bond or a double bond, R 2 is a hydrogen atom or an optionally substituted hydrocarbon group, X is an optionally substituted spacer having 1 to 6 atoms, ring C is (1) an optionally substituted homocycle or (2) an optionally substituted heterocycle other than a ring represented by (II) (X′ is S, O, SO, or CH 2 ), and at least one of ring B and ring C has substituent(s), provided that N-(1S,2R)-1-(3,5-difluorobenzyl)-3-[(3-ethylbenzyl)amino]-2-hydroxypropyl}-5,6-dimethyl-4-oxo-1,4-dihadrothieno[2,3-d]pyrimidine-2-carboxamide is excluded, or a salt thereof.
  • US9212149B2
    申请人:——
    公开号:US9212149B2
    公开(公告)日:2015-12-15
查看更多